Javascript must be enabled to continue!
Cullin 1 is not associated with late-onset preeclampsia
View through CrossRef
BackgroundLate-onset preeclampsia (PE) is preeclampsia occurring after 34 weeks of gestational age or later. Cullin 1 (CUL1), a proangiogenic protein, is expressed in the placenta, where an imbalance between proangiogenic and antiangiogenic proteins during gestation can cause disturbance of trophoblast invasion. This defect results in vascular ischemia that may produce preeclampsia. The objective of this study was to determine the correlation between CUL1 as proangiogenic factor and late-onset preeclampsia. MethodsThis study was of analytical observational cross-sectional design and involved 44 preeclampsia patients with ³34 weeks of gestational age (late-onset PE). The CUL1 level in the subjects’ sera, taken before they gave birth, and in homogenates of their placenta, obtained per vaginam or by cesarean section, were examined by the ELISA technique. Statistical analysis was performed with the Spearman correlation test with significant p value of <0.05.ResultsMedian maternal age was 31 years and median gestational age was 37 weeks. Median serum CUL1 was 41.78 pg/mL and median placental homogenate CUL1 was 32.24 pg per milligram of total placental tissue protein. There was no significant correlation between serum CUL1 level and late-onset preeclampsia (r=-0.281; p=0.065). There was also no significant correlation between placental CUL1 level and late-onset preeclampsia (r=-0.166; p=0.281).ConclusionSerum CUL1 and placental CUL1 were not correlated with late-onset preeclampsia. However, this study indicated that low serum CUL1 tends to prolong gestational age in preeclampsia.
Title: Cullin 1 is not associated with late-onset preeclampsia
Description:
BackgroundLate-onset preeclampsia (PE) is preeclampsia occurring after 34 weeks of gestational age or later.
Cullin 1 (CUL1), a proangiogenic protein, is expressed in the placenta, where an imbalance between proangiogenic and antiangiogenic proteins during gestation can cause disturbance of trophoblast invasion.
This defect results in vascular ischemia that may produce preeclampsia.
The objective of this study was to determine the correlation between CUL1 as proangiogenic factor and late-onset preeclampsia.
MethodsThis study was of analytical observational cross-sectional design and involved 44 preeclampsia patients with ³34 weeks of gestational age (late-onset PE).
The CUL1 level in the subjects’ sera, taken before they gave birth, and in homogenates of their placenta, obtained per vaginam or by cesarean section, were examined by the ELISA technique.
Statistical analysis was performed with the Spearman correlation test with significant p value of <0.
05.
ResultsMedian maternal age was 31 years and median gestational age was 37 weeks.
Median serum CUL1 was 41.
78 pg/mL and median placental homogenate CUL1 was 32.
24 pg per milligram of total placental tissue protein.
There was no significant correlation between serum CUL1 level and late-onset preeclampsia (r=-0.
281; p=0.
065).
There was also no significant correlation between placental CUL1 level and late-onset preeclampsia (r=-0.
166; p=0.
281).
ConclusionSerum CUL1 and placental CUL1 were not correlated with late-onset preeclampsia.
However, this study indicated that low serum CUL1 tends to prolong gestational age in preeclampsia.
Related Results
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
<p>Preeclampsia is a hypertensive disorder of pregnancy that is diagnosed after the 20th week of gestation. It is defined by the American College of Obstetrics and Gynecology...
Hubungan Onset Preeklamsia dengan Luaran Neonatus di RSUP Dr.Sardjito Yogyakarta
Hubungan Onset Preeklamsia dengan Luaran Neonatus di RSUP Dr.Sardjito Yogyakarta
Background: Preeclampsia is one of the leading causes of death for both mother and fetus. Preeclampsia is divided into two categories of onset, for preeclampsia that begins at gest...
Single vs. Recurrent Episodes of Preeclampsia-population–based Epidemiological and Clinical Characteristics
Single vs. Recurrent Episodes of Preeclampsia-population–based Epidemiological and Clinical Characteristics
Abstract
Objective:
The aims of this study were to determine the differences between women with single vs. recurrent episodes of preeclampsia in ...
Urinary KIM-1 Levels Normal Pregnancy vs Early-Onset Preeclampsia, and Late-Onset Preeclampsia
Urinary KIM-1 Levels Normal Pregnancy vs Early-Onset Preeclampsia, and Late-Onset Preeclampsia
Introduction : Preeclampsia is a hypertensive disorder of pregnancy that contributes to high maternal mortality rates. Kidney Injury Molecule-1 (KIM-1) has been identified as a pot...
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Objetivo: Determinar las complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima - 2021 Metodología: Estudio de tipo Observacional, trasvers...
Clinical presentation, maternal-fetal, and neonatal outcomes of early-onset versus late onset preeclampsia-eclampsia syndrome in a teaching hospital in a low-resource setting: A retrospective cohort study
Clinical presentation, maternal-fetal, and neonatal outcomes of early-onset versus late onset preeclampsia-eclampsia syndrome in a teaching hospital in a low-resource setting: A retrospective cohort study
Background
Pre-eclampsia-eclampsia syndrome remains the leading cause of maternal and neonatal mortality worldwide. Both from pathophysiologic and clinical stand points, early and ...
Serum catestatin level in preeclampsia
Serum catestatin level in preeclampsia
Background/Aim: Preeclampsia, a significant cause of maternal morbidity and mortality, is linked to increased cardiovascular risks. Catestatin regulates cardiovascular function whi...
Association between maternal ABO blood group and preeclampsia: a prospective cohort study
Association between maternal ABO blood group and preeclampsia: a prospective cohort study
Background:
Preeclampsia is a leading cause of maternal morbidity and mortality. Various predictive methods exist, but none are without flaws. Risk factors vary...

